Drug profile · INN
tofacitinib
XELJANZ
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
tofacitinib (XELJANZ) is an FDA-listed pharmaceutical active ingredient. Associated with Pfizer Australia Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN tofacitinib
Brand XELJANZ
Route ORAL
Formulation TABLET
ATC code L04AF01
Originator Pfizer Australia Pty Ltd
Frequently asked questions
What is tofacitinib?
tofacitinib (XELJANZ) is an FDA-listed pharmaceutical active ingredient. Associated with Pfizer Australia Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tofacitinib?
XELJANZ is a marketed brand name for tofacitinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tofacitinib?
tofacitinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.